Cleveland, Ohio-based eClinical company Datatrak has formed an enterprise relationship with GP-Pharm, a Barcelona,Spain-based pharmaceutical company focusing on the development of hormonal and cytotoxic drugs. GP-Pharm is a part of the Lipotec Group, a Spanish-owned biochemical manufacturer and supplier of pharmaceutical, cosmetic and food ingredients. Initially, the contract calls for the company to use Datatrak’s EDC Version 4.0 product for a block of five clinical trials enrolling 730 patients and 145 sites. The trials are expected to be conducted in the next 14 months.

“The ordering of blocks of clinical trials under an enterprise business model structure represents another example of the stepwise progression of this market away from the inefficiencies and higher costs of the trial-by-trial behavior that had previously been the only means of contracting for electronic clinical trials,” said Jeffrey Green, president and chief executive officer at Datatrak.